|
In the ongoing saga concerning Jeremy Mayfield and his violation of NASCAR’s Substance Abuse Policy, Ramsey Poston, Managing Director of Corporate Communications for NASCAR, announced Friday NASCAR has filed a countersuit against Mayfield.
“NASCAR today responded to the Jeremy Mayfield lawsuit by denying each of his claims and countersuing Mayfield for willfully violating NASCAR’s Substance Abuse Policy, breach of contract and defrauding NASCAR and its competitors of earnings,” Poston explained. “NASCAR’s counter-claim states Mayfield knowingly participated in NASCAR-sanctioned competition using a combination of drugs in violation of the Substance Abuse Policy and in doing so violated his contract with NASCAR and the standards of care that he owed fellow drivers and spectators.
“Mayfield’s willful misconduct at the racetrack while an illegal substance in his system is evidence that he presented a danger to himself and others. In addition to the use of illegal drugs, Mayfield has now admitted he used another drug without informing NASCAR. When he consumed that drug in conjunction with another medication he exceeded safe levels and violated NASCAR’s Substance Abuse Policy. “In regards to Aegis Laboratories, it is a world-class forensic science facility with impeccable credentials for conducting and verifying substance abuse or misuse. NASCAR continues to stand by Aegis, its methods and the results of all tests conducted on behalf of NASCAR.” Judge Forrest Bridges of Mecklenburg County, North Carolina has placed a gag order on both parties, so Poston was unable to elaborate on what drug Mayfield willfully violated the policy with. According to Mayfield’s suit however, the driver was prescribed Adderall-XR for Attention Deficit Hyperactivity Disorder in March of this year. NASCAR is claiming Mayfield never informed the sanctioning body or Dr. David Black of Aegis of the prescription and was in violation. In addition, NASCAR is claiming Mayfield competed in a number of events with the knowledge he was in violation of the Substance Abuse Policy and therefore took money away from NASCAR and other competitors.
“Had we known that he had been on the medication he was on and certainly had we known there were illegal substances involved we would not have allowed him to compete,” Poston added. “So, in effect he took money away from other potential competitors that could have gained those earnings.” No date has been set for NASCAR’s countersuit and Mayfield’s lawsuit has now been moved to a federal court. This story will continue to develop as the weeks and months go on and HardcoreRaceFans.com will be there to bring you the latest, so be sure to check back to stay up to date with the latest on this ongoing story. MORE NASCAR NEWS
|